Kymera Therapeutics, Inc.
KYMR
52 insider filings · Latest: Jul 27, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | Mar 23 8:36 PM | JEREMY CHADWICK | Proposed Sale | 115,977 | $77.91 | $9.0M | — | View → |
| Mar 20, 2026 | Mar 20 10:30 PM | Pamela EspositoDirector | Sale | 2,500 | $79.15 | $197.9K | 0(D) | View → |
| Mar 20, 2026 | Mar 20 8:35 PM | PAMELA ESPOSITO | Proposed Sale | 2,500 | $79.57 | $198.9K | — | View → |
| Mar 11, 2026 | Mar 11 10:51 PM | Jeremy G ChadwickChief Operating Officer | Sale | 25,758 | $83.30 | $2.1M | 68,052(D) | View → |
| Mar 11, 2026 | Mar 11 8:40 PM | JEREMY CHADWICK | Proposed Sale | 25,758 | $84.58 | $2.2M | — | View → |
| Mar 4, 2026 | Mar 4 11:00 PM | Jeremy G ChadwickChief Operating Officer | Sale | 3,919 | $85.30 | $334.3K | 73,810(D) | View → |
| Mar 2, 2026 | Mar 4 11:00 PM | Jeremy G ChadwickChief Operating Officer | Sale | 2,039 | $88.93 | $181.3K | 77,729(D) | View → |
| Mar 4, 2026 | Mar 4 11:00 PM | Jared GollobChief Medical Officer | Sale | 4,895 | $85.30 | $417.5K | 117,134(D) | View → |
| Mar 2, 2026 | Mar 4 11:00 PM | Jared GollobChief Medical Officer | Sale | 5,613 | $88.93 | $499.1K | 122,029(D) | View → |
| Mar 4, 2026 | Mar 4 11:00 PM | Bruce N. JacobsChief Financial Officer | Sale | 4,895 | $85.30 | $417.5K | 232,588(D) | View → |
| Mar 2, 2026 | Mar 4 11:00 PM | Bruce N. JacobsChief Financial Officer | Sale | 7,576 | $88.93 | $673.7K | 237,483(D) | View → |
| Mar 2, 2026 | Mar 4 9:30 PM | Bruce BoothDirector | Sale | 81,866 | $90.13 | $7.4M | 675,341(I) | View → |
| Mar 2, 2026 | Mar 2 10:11 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 25,000 | $91.35 | $2.3M | — | View → |
| Mar 2, 2026 | Mar 2 10:11 PM | Atlas Venture Fund X, LP | Proposed Sale | 200,000 | $91.35 | $18.3M | — | View → |
| Mar 2, 2026 | Mar 2 10:08 PM | Gollob Jared | Proposed Sale | 10,613 | $90.10 | $956.2K | — | View → |
| Mar 2, 2026 | Mar 2 10:07 PM | Chadwick Jeremy G | Proposed Sale | 6,206 | $90.10 | $559.2K | — | View → |
| Mar 2, 2026 | Mar 2 10:06 PM | Jacobs Bruce N. | Proposed Sale | 12,576 | $90.10 | $1.1M | — | View → |
| Feb 25, 2026 | Feb 25 10:24 PM | Nello MainolfiDirector, Chief Executive Officer | Sale | 30,000 | $90.26 | $2.7M | 666,195(D) | View → |
| Feb 25, 2026 | Feb 25 9:03 PM | Mainolfi Nello | Proposed Sale | 30,000 | $91.40 | $2.7M | — | View → |
| Feb 20, 2026 | Feb 20 10:30 PM | Pamela EspositoDirector | Sale | 2,500 | $87.31 | $218.3K | 0(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 4 11:00 PM | Bruce N. JacobsChief Financial Officer | Grant/Award | 35,300 | $90.10 | 35,300(D) | View → |
| Mar 2, 2026 | Mar 4 11:00 PM | Nello MainolfiDirector, Chief Executive Officer | Grant/Award | 215,000 | $90.10 | 215,000(D) | View → |
| Feb 25, 2026 | Feb 25 10:24 PM | Nello MainolfiDirector, Chief Executive Officer | Option Exercise | 30,000 | $2.08 | 245,559(D) | View → |
| Feb 20, 2026 | Feb 20 10:30 PM | Pamela EspositoDirector | Option Exercise | 2,500 | $49.10 | 2,500(D) | View → |
| Jan 20, 2026 | Jan 20 11:30 PM | Pamela EspositoDirector | Option Exercise | 5,500 | $49.10 | 5,000(D) | View → |
| Dec 31, 2025 | Dec 31 10:23 PM | Nello MainolfiDirector, Chief Executive Officer | Option Exercise | 30,000 | $2.08 | 275,559(D) | View → |
← Previous
Page 3 of 3